Skip to main content

S. 3342

Referred to Committee

Zero Tolerance for Deceptive Fentanyl Trafficking Act

Introduced 2/27/2020•116th Congress•Senate

Latest Action

Read twice and referred to the Committee on the Judiciary.

2/27/2020 • Senate

Summary

Zero Tolerance for Deceptive Fentanyl Trafficking Act

This bill adds five fentanyl analogues and the entire category of fentanyl-related substances to schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

Additionally, the bill establishes a new criminal offense and penalties with respect to the deceptive sale of fentanyl, fentanyl analogues, or fentanyl-related substances.

Introduced in Senate • 2/27/2020

Enter your district to see how this bill affects your community
-

Topics & Subjects

Border security and unlawful immigrationCriminal procedure and sentencingDrug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesMarketing and advertising

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (3)

Party Breakdown

0
Democrats
3
Republicans
0
Independents

Sponsor

S[
Sen. Cotton, Tom [R-AR]

Republican • AR

Sponsored 2/27/2020

Cosponsors (2)

S[
Sen. Loeffler, Kelly [R-GA]

R-GA

Joined 2/27/2020

S[
Sen. Blackburn, Marsha [R-TN]

R-TN

Joined 2/27/2020

Bill Journey

Originated in the Senate

Introduced

February 27, 2020

Read twice and referred to the Committee on the Judiciary.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in Senate2/27/2020

Details

Bill TypeS
Current StatusReferred to Committee
Cosponsors2